Samsara BioCapital, L.P. 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA | Samsara BioCapital, L.P. | 3,281,766 4.980% | 501,505 (+18.04%) | Filing |
| 2023-08-25 4:15 pm Purchase | 2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA | Samsara BioCapital, L.P. | 2,780,261 5.600% | 2,780,261 (New Position) | Filing |